Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Asthma 2Smoking 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Multiple Myeloma 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Tobacco Use Cessation Devices 5Surveys and Questionnaires 4Standard of Care 3Exercise 3Ethanol 3Varenicline 2Tomography, X-Ray Computed 2Tobacco Products 2Smoking Devices 2Radiotherapy 2Motivational Interviewing 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Videotape Recording 1Transcranial Direct Current Stimulation 1Tablets 1Restraint, Physical 1Radon 1Psychiatric Rehabilitation 1Preoperative Exercise 1Practice Guidelines as Topic 1Phlebotomy 1Patient Navigation 1Nutritional Support 1Nicotine Replacement Therapy 1Nicotine 1Mindfulness-Based Stress Reduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smoking × Budesonide × Clear all
NCT00321893 2016-01-25

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
225 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡